Ardelyx (ARDX) EBITDA Margin Growth (5y) (2018 - 2026)
Ardelyx (ARDX) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,154.00 |
| Dec 31, 2025 | 153,215.00 |
| Sep 30, 2025 | 76,984.00 |
| Jun 30, 2025 | 130,372.00 |
| Mar 31, 2025 | 174,560.00 |
| Dec 31, 2024 | 84,469.00 |
| Sep 30, 2024 | 73,540.00 |
| Jun 30, 2024 | 13.79 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Mar 31, 2023 | 53,303.00 |
| Sep 30, 2020 | -54,889.00 |
| Jun 30, 2020 | -136,838.00 |
| Mar 31, 2020 | -173,532.00 |
| Dec 31, 2019 | -77,563.00 |
| Sep 30, 2019 | -73,419.00 |
| Jun 30, 2019 | -13.80 Mn |
| Dec 31, 2018 | -3.22 Mn |
| Sep 30, 2018 | -1.38 Mn |